Trial Profile
Study of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide in Japanese essential hypertensive patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/azilsartan (Primary) ; Amlodipine/azilsartan/hydrochlorothiazide (Primary) ; Hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Adverse reactions; Therapeutic Use
- 14 Sep 2018 New trial record